bpc 157 randomized controlled trial musculoskeletal BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded Wellness clinics promote the use

J Appl Physiol 110:774780 Chang CH, Tsai WC, Hsu YH, Pang JH (2014) Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts

As one set of researchers bluntly concluded: using BPC-157 may not be the right choice, especially in situations where we are not aware of the presence of cancer cells in our body What Do Human Studies Say About Safety and Cancer Risk

These products are almost always labeled for research purposes only or not for human use. That labeling exists for a reason

[1] According to the researchers TGF-beta1 induction of angiogenesis requires a rapid and transient apoptotic effect mediated by VEGF/VEGFR2. AHK-Cu, by enhancing levels of the Vascular Endothelial Growth Factor, may possibly activate fibroblasts and endothelial cells